» Articles » PMID: 25511377

Role of Chitinase 3-like-1 and Semaphorin 7a in Pulmonary Melanoma Metastasis

Overview
Journal Cancer Res
Specialty Oncology
Date 2014 Dec 17
PMID 25511377
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The prototypic chitinase-like protein Chi3l1 is induced in cancers and portends a poor prognosis, but whether it contributes to cancer progression is unknown. To address this gap in knowledge, we investigated the production of Chi3l1 in melanoma lung metastases. We found that Chi3l1 was induced during pulmonary melanoma metastasis and that this induction was regulated by the semaphorin Sema7a, interacting in stimulatory or inhibitory ways with its β1 integrin or Plexin C1 receptors, respectively. In mouse strains with genetic deletions of Chi3l1 or Sema7a, there was a significant reduction in pulmonary metastasis. Notably, antiserum raised against Chi3l1 or Sema7a phenocopied the reduction produced by genetic deletions. Melanoma lung metastasis was also decreased in the absence of IL13Rα2, a recently identified receptor for Chi3l1, consistent with a key role for Chi3l1 in melanoma spread. We confirmed roles for Sema7a and Chi3l1 in pulmonary metastasis of EMT6 breast cancer cells. Taken together, our studies establish a novel pathway through which Sem7a and its receptors regulate Chi3l1, revealing a host axis involving IL13Rα2 that plays a critical role in generating a pulmonary microenvironment that is critical to license metastasis.

Citing Articles

Pan-Cancer Analysis of the Prognostic and Immunological Role of SEMA7A.

Yang L, Zhang S, Zheng L, Kong F, Dang W, Shen S Int J Gen Med. 2024; 17:6443-6461.

PMID: 39735166 PMC: 11682669. DOI: 10.2147/IJGM.S499872.


SEMA7A as a Novel Prognostic Biomarker and Its Correlation with Immune Infiltrates in Breast Cancer.

Zhang S, Kong F, Zheng L, Li X, Jia L, Yang L Int J Gen Med. 2024; 17:4081-4099.

PMID: 39295856 PMC: 11410036. DOI: 10.2147/IJGM.S474827.


Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer.

Kamle S, Ma B, Schor G, Bailey M, Pham B, Cho I Transl Oncol. 2024; 49:102108.

PMID: 39178575 PMC: 11388375. DOI: 10.1016/j.tranon.2024.102108.


Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models.

Salembier R, De Haes C, Bellemans J, Demeyere K, Van Den Broeck W, Sanders N Breast Cancer Res. 2024; 26(1):63.

PMID: 38605414 PMC: 11007917. DOI: 10.1186/s13058-024-01815-8.


The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases.

Chang M, Chen C, Chiang P, Chiang Y Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543093 PMC: 10976000. DOI: 10.3390/ph17030307.


References
1.
Czopik A, Bynoe M, Palm N, Raine C, Medzhitov R . Semaphorin 7A is a negative regulator of T cell responses. Immunity. 2006; 24(5):591-600. DOI: 10.1016/j.immuni.2006.03.013. View

2.
Chiang A, Massague J . Molecular basis of metastasis. N Engl J Med. 2008; 359(26):2814-23. PMC: 4189180. DOI: 10.1056/NEJMra0805239. View

3.
Barderas R, Bartolome R, Fernandez-Acenero M, Torres S, Casal J . High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res. 2012; 72(11):2780-90. DOI: 10.1158/0008-5472.CAN-11-4090. View

4.
Zheng T, Liu W, Oh S, Zhu Z, Hu B, Homer R . IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung. J Immunol. 2007; 180(1):522-9. DOI: 10.4049/jimmunol.180.1.522. View

5.
Schmidt H, Johansen J, Sjoegren P, Christensen I, Sorensen B, Fode K . Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma. J Clin Oncol. 2006; 24(5):798-804. DOI: 10.1200/JCO.2005.03.7960. View